Cargando…
Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390030/ https://www.ncbi.nlm.nih.gov/pubmed/34446694 http://dx.doi.org/10.1038/s41392-021-00737-7 |
| _version_ | 1783743003647541248 |
|---|---|
| author | Hua, Chen Ma, Qinhai Zhu, Yun Xia, Shuai Liu, Zezhong Li, Lin Lu, Lu Zhong, Nanshan Liu, Shuwen Yang, Zifeng Jiang, Shibo |
| author_facet | Hua, Chen Ma, Qinhai Zhu, Yun Xia, Shuai Liu, Zezhong Li, Lin Lu, Lu Zhong, Nanshan Liu, Shuwen Yang, Zifeng Jiang, Shibo |
| author_sort | Hua, Chen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8390030 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83900302021-08-27 Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation Hua, Chen Ma, Qinhai Zhu, Yun Xia, Shuai Liu, Zezhong Li, Lin Lu, Lu Zhong, Nanshan Liu, Shuwen Yang, Zifeng Jiang, Shibo Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-08-26 /pmc/articles/PMC8390030/ /pubmed/34446694 http://dx.doi.org/10.1038/s41392-021-00737-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Hua, Chen Ma, Qinhai Zhu, Yun Xia, Shuai Liu, Zezhong Li, Lin Lu, Lu Zhong, Nanshan Liu, Shuwen Yang, Zifeng Jiang, Shibo Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation |
| title | Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation |
| title_full | Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation |
| title_fullStr | Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation |
| title_full_unstemmed | Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation |
| title_short | Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation |
| title_sort | repurposing of a clinically used anti-hpv agent to prevent and treat sars-cov-2 infection as an intranasal formulation |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390030/ https://www.ncbi.nlm.nih.gov/pubmed/34446694 http://dx.doi.org/10.1038/s41392-021-00737-7 |
| work_keys_str_mv | AT huachen repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT maqinhai repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT zhuyun repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT xiashuai repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT liuzezhong repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT lilin repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT lulu repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT zhongnanshan repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT liushuwen repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT yangzifeng repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation AT jiangshibo repurposingofaclinicallyusedantihpvagenttopreventandtreatsarscov2infectionasanintranasalformulation |